ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1890

Cellular Origin and Functions of Osteoclasts in Inflammatory Arthritis

Hannah Nelson1, Ellen Gravallese2, Julia Charles1 and Christian Jacome-Galarza1, 1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA

Meeting: ACR Convergence 2021

Keywords: Animal Model, Monocytes/macrophages, osteoclast, Pathology Bone Joint, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: RA – Animal Models (1889–1892)

Session Type: Abstract Session

Session Time: 9:15AM-9:30AM

Background/Purpose: Inflammatory arthritis (IA) is an autoimmune disease targeting multiple joints and characterized by joint destruction caused by osteoclasts (OC), leading to physical disability. However, the precise cellular origins of OC are poorly understood. Myeloid lineage cells including OC and macrophages can derive from either hematopoietic stem cells (HSC) or erythro-myeloid progenitors (EMP). Previous studies in vitro suggest that in IA, HSC-derived monocytes differentiate into OC and others showed that macrophages can fuse to form OC under the influence of inflammatory cytokines. We hypothesized that in IA, embryonically derived Erythro-Myeloid Progenitor macrophages and Hematopoietic Stem Cell-derived progenitors can independently contribute to the formation of OC in vivo. These cell lineage tracing systems will allow to discriminate among distinct OC populations by their cell surface phenotype and selectively target them for therapeutic purpose.

Methods: To test this hypothesis, we used bone frozen sections and immunofluorescence, as well as flow cytometry (FACS) from cell lineage tracing systems, to discriminate among these progenitors. We used Flt3Cre;Rosa26LSL-YFP mice to label HSC and their progeny and both Csf1rMer-iCre-Mer;Rosa26LSL-tdTomato and Cx3cr1CreERT2;Rosa26LSL-tdTomato mice, pulsed with 4-hydroxytamoxifen at E8.5 and E9.75 respectively, to label EMP-derived progenitors.

Results: Histology of ankle joints from healthy Flt3Cre;Rosa26LSL-YFP embryos at E16.5, newborn at P0 and 8 week-old mice showed that ~7 % of synovial F4/80+ or CD68+ cells were of HSC origin, suggesting that EMPs are the major source of synovial macrophages. We confirmed, using both Csf1rMer-iCre-Mer;Rosa26LSL-tdTomato and Cx3cr1CreERT2;Rosa26LSL-tdTomato mice, that ~40% of all F4/80+ synovial macrophages were TdTomato+, showing for the first time an EMP-origin. To test the HSC origin of OC in IA, adult Flt3Cre;Rosa26LSL-YFP mice were treated with K/BxN arthritogenic serum and ankle joints were harvested at day 10 (peak inflammation). Unexpectedly, we found that only 56% of OC were YFP-positive, indicating that a large proportion of synovial OC are not HSC-derived. Further, we identified CD68+TRAP+ cells localized to periosteal surfaces as candidate progenitors of synovial OC. Consistent with the dual origin of synovial OC, CD68+TRAP+ progenitors derive from both HSC (27%) and non-HSC (73%) lineages.

Conclusion: These data suggest that both HSC-derived and EMOP-derived osteoclast precursor cells independently contribute to OC formation in IA. These cell lineage tracing systems will help us to identify unique differences among OC of distinct origins. These differences will allow for differential targeting of OC via unique cell surface markers and for the development of new targets to inhibit OC formation and prevent bone and cartilage erosions in IA.


Disclosures: H. Nelson, None; E. Gravallese, None; J. Charles, Ultragenyx, 1; C. Jacome-Galarza, None.

To cite this abstract in AMA style:

Nelson H, Gravallese E, Charles J, Jacome-Galarza C. Cellular Origin and Functions of Osteoclasts in Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/cellular-origin-and-functions-of-osteoclasts-in-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cellular-origin-and-functions-of-osteoclasts-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology